Ozan Pamir
Director of Finance/CFO at 180 LIFE SCIENCES CORP.
Net worth: 1 102 $ as of 2024-03-30
Profile
Ozan Pamir is currently the Chief Financial Officer & Secretary at 180 Life Sciences Corp.
He previously worked as the Chief Financial Officer & Director at Unify Pharmaceuticals Corp.
from 2019 to 2021, and as the Chief Financial Officer at Global Gaming Technologies Corp.
in 2019.
Prior to that, he served as the Vice President-Investment Banking at Echelon Wealth Partners, Inc. from 2014 to 2018.
Mr. Pamir's education includes an undergraduate degree from McGill University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
180 LIFE SCIENCES CORP.
0.06% | 2023-12-17 | 473 ( 0.06% ) | 1 102 $ | 2024-03-30 |
Ozan Pamir active positions
| Companies | Position | Start |
|---|---|---|
| 180 LIFE SCIENCES CORP. | Director of Finance/CFO | 2018-09-30 |
Former positions of Ozan Pamir
| Companies | Position | End |
|---|---|---|
Unify Pharmaceuticals Corp.
 Unify Pharmaceuticals Corp. BiotechnologyHealth Technology Unify Pharmaceuticals Corp. is an American biotech company that focuses on developing drugs for neurodegenerative diseases. The private company is based in Tennessee. | Director of Finance/CFO | 2021-06-30 |
Enosi Life Sciences Corp.
 Enosi Life Sciences Corp. BiotechnologyHealth Technology Enosi Life Sciences Corp. is a drug research and development company that focuses on providing therapeutics for autoimmune diseases and cancer. The private company is based in San Diego, CA, and was founded in 2018 by H. Michael Shepard and Marc Feldmann. Enosi Life Sciences combines their expertise with Dr. James N. Woody's medical, scientific, and management expertise to expand therapeutic options. The company was founded by Professor Sir Marc Feldmann and Dr. H. Michael Shepard, who are world-renowned scientists in the field of cancer and autoimmune diseases. Patrick W. Gray has been the CEO of the company since 2021. | Director of Finance/CFO | - |
| GLOBAL GAMING TECHNOLOGIES CORP. | Director of Finance/CFO | 2019-08-14 |
Echelon Wealth Partners, Inc.
 Echelon Wealth Partners, Inc. Investment Banks/BrokersFinance Echelon Wealth Partners, Inc. (Echelon) is the wealth management and capital markets subsidiary of Echelon Wealth Holdings, Inc. in Canada. The firm was founded in 2010 by Robert Furse and David Cusson. Headquartered in Toronto, Echelon provides creative solutions and execution to their institutional and retail clients. | Corporate Officer/Principal | 2018-09-30 |
Training of Ozan Pamir
| McGill University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| GLOBAL GAMING TECHNOLOGIES CORP. | Finance |
| 180 LIFE SCIENCES CORP. | Health Technology |
| Private companies | 3 |
|---|---|
Echelon Wealth Partners, Inc.
Echelon Wealth Partners, Inc. Investment Banks/BrokersFinance Echelon Wealth Partners, Inc. (Echelon) is the wealth management and capital markets subsidiary of Echelon Wealth Holdings, Inc. in Canada. The firm was founded in 2010 by Robert Furse and David Cusson. Headquartered in Toronto, Echelon provides creative solutions and execution to their institutional and retail clients. | Finance |
Enosi Life Sciences Corp.
Enosi Life Sciences Corp. BiotechnologyHealth Technology Enosi Life Sciences Corp. is a drug research and development company that focuses on providing therapeutics for autoimmune diseases and cancer. The private company is based in San Diego, CA, and was founded in 2018 by H. Michael Shepard and Marc Feldmann. Enosi Life Sciences combines their expertise with Dr. James N. Woody's medical, scientific, and management expertise to expand therapeutic options. The company was founded by Professor Sir Marc Feldmann and Dr. H. Michael Shepard, who are world-renowned scientists in the field of cancer and autoimmune diseases. Patrick W. Gray has been the CEO of the company since 2021. | Health Technology |
Unify Pharmaceuticals Corp.
Unify Pharmaceuticals Corp. BiotechnologyHealth Technology Unify Pharmaceuticals Corp. is an American biotech company that focuses on developing drugs for neurodegenerative diseases. The private company is based in Tennessee. | Health Technology |
- Stock Market
- Insiders
- Ozan Pamir
